2) the monoclonal antibody treatment Trump received for his covid-19 infection in 2020 was developed by Renegeron with a $611 million grant from the department of Health and Human Services, not to mention all the NIH-funded basic research that made it possible; www.usaspending.gov/award/CONT_A...